FDAFDA · Food and drugs·Recall number D-0606-2025
Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Published September 10, 2025 · Recall initiated: July 9, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recall details
- Manufacturer
- Boothwyn Pharmacy LLC
- Distributor
- U.S. Nationwide
- Lot
- 03202025@5, 03202025@6, 03202025@7, 03202025@8 BUD 07/18/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.